The effectiveness of cancer vaccines could be dramatically boosted by first loading the cancer antigens into silicon microparticles, report scientists from Houston Methodist and two other institutions in an upcoming Cell Reports (early online).
(Business Wire India); Teva Pharmaceutical Industries Ltd. has announced that an updated investor presentation in connection with its proposed combination with Mylan N.V. is available on the Investor Relations section of the Company’s website and will be filed with the Securities and Exchange Commission (“SEC”).

